SaluTech

SaluTech has developed a conductive biomaterial (CBM) to treat the underlying cause of arrhythmia. This CBM has the ability to reduce/diminish arrhythmia while being nontoxic, biocompatible, and inexpensive to produce.

SaluTech is a business in health.

Within the health space, the company focuses on its core offering rather than a broad product line.

It is recorded at the Creative Destruction Lab alumni company stage.

Website: www.salutech.it